Bipartisan Pennsylvania senators have introduced a bill that would allow terminally ill patients to use of medical marijuana in hospitals. Similar to a law previously enacted in California, the Pennsylvania legislation from Sen. John Kane …
TNG260 is a first-in-class, highly selective CoREST complex inhibitor currently being evaluated with pembrolizumab in the dose expansion phase of the TNG260 Phase 1/2 trial. The trial is currently enrolling patients with STK11-mutant/RAS…
A new large-scale study has found that nicotinamide, a common vitamin B3 supplement, may significantly reduce the risk of skin cancer recurrence. Dermatologists have been recommending the supplement nicotinamide to patients with a history…
With easy access to photos, videos and personal information, a cybercriminal can create fraudulent accounts and donation campaigns — especially now, in an era of on-demand generative AI, deepfake apps, and voice cloning software.
'Most people think carcinomatosis is a death sentence, but there are different treatment modalities that I offer to patients. And that's something that is pretty unique to UT Health San Antonio,' said Dr. Mio Kitano, a surgical oncologist.
When cancer cells are physically squeezed, they mount an instant, high-energy defense by rushing mitochondria to the cell nucleus, unleashing a surge of ATP that fuels DNA repair and survival. This newly discovered mechanism, visualized in…
News Ghana, Latest Updates and Breaking News of Ghana, VEK, https://www.newsghana.com.gh/giving-hope-to-breast-cancer-patients-deltas-continuous-partnership-with-bci/Delta Air Lines has reaffirmed its commitment to the fight against breast…
The Access to Breast Cancer Diagnosis Act would require federally regulated health plans to cover diagnostic and supplemental breast imaging — fully, with no out-of-pocket cost to patients.
A Scandinavian clinical trial has revealed that low-dose aspirin can halve the risk of colon and rectal cancer recurrence in patients with specific genetic mutations. The research, involving over 3,500 patients, is the first randomized…